What Is Addyi and How Does It Work
Addyi (flibanserin) is an FDA-approved prescription medication for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). It targets brain neurotransmitters, specifically serotonin, to modulate sexual desire. The drug is not a hormone and is not intended for use after menopause. More background on the approval is available on the FDA website here.
Addyi must be taken once daily at bedtime because it can cause severe low blood pressure and fainting when combined with alcohol or certain other medications. The FDA requires a Risk Evaluation and Mitigation Strategy (REMS) program to ensure safe dispensing. The REMS program details are accessible on the FDA REMS page.
Clinical Efficacy and Real-World Outcomes
In pivotal clinical trials, women taking Addyi experienced a statistically significant increase in sexually satisfying events per month compared to placebo. The FDA approval was based on trials involving thousands of premenopausal women, showing modest but measurable improvement in desire and distress related to low libido. The FDA approval label is publicly available on the FDA drugs page.
Real-world data and post-marketing studies continue to track long-term outcomes, including patient-reported satisfaction and adherence. Healthcare providers often assess treatment response after 8 to 12 weeks of consistent use. The American College of Obstetricians and Gynecologists provides clinical guidance on HSDD treatment options on its patient resources.
Cost, Insurance Coverage, and How to Access Addyi
Addyi is typically covered by most commercial insurance plans, including major pharmacy benefit managers, though out-of-pocket costs vary by plan and pharmacy. Manufacturer savings cards and copay assistance programs may reduce the price for eligible patients. Pricing and coverage details can be verified on the manufacturer's official site here.
Telehealth platforms and specialized women's health clinics have expanded access to Addyi by offering remote consultations and prescription services. Patients should consult a licensed healthcare provider to determine if Addyi is appropriate based on their medical history and current medications. The Substance Abuse and Mental Health Services Administration provides a treatment locator tool on its health services page.